Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Promoter polymorphism of IL-10 and severity of multiple sclerosis.

Acta neurologica Scandinavica - 1 Dec 2003

Luomala M, Lehtimäki T, Huhtala H, Ukkonen M, Koivula T, Hurme M, Elovaara I

Abstract excerpt

Functional polymorphisms of the genes for interleukin-10 (IL-10; promoter position -1082), chemokine receptor-5 (CCR5 32 bp deletion), tumor necrous factor-alpha (TNFalpha promoter position -308) and cytotoxic T-lymphocyte antigen-4 (CTLA-4 exon 1 position 49) were investigated for possible influence on susceptibility and outcome of multiple sclerosis (MS). The polymorphisms were typed by polymerase chain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Genetic Predisposition to Disease
Share to Interleukin-10

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Multiple Sclerosis

Share to Polymerase Chain Reaction

Share to Polymorphism, Genetic

Share to Promoter Regions, Genetic

Share to Severity of Illness Index

Source

Identifiers

PMID: 14616291
DOI: 10.1034/j.1600-0404.2003.00165.x

Genes

CCR5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Promoter polymorphism of IL-10 and severity of multiple sclerosis.PMID 14616291Read ↗

Interleukin-10 promoter polymorphisms in patients with multiple sclerosis.Semantic proximity Read ↗

Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis.Semantic proximity Read ↗

Genetic predisposition of IL-10 promoter polymorphisms with risk of multiple sclerosis: A meta-analysis.Semantic proximity Read ↗

Association between interleukin-10 gene polymorphisms and multiple sclerosis susceptibility: evidence from a meta-analysis.Semantic proximity Read ↗

Interleukin 10 gene polymorphism in Iranian patients with multiple sclerosis.Semantic proximity Read ↗

Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression.Semantic proximity Read ↗

Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients.Semantic proximity Read ↗

Interleukin-10 polymorphisms in Spanish multiple sclerosis patients.Semantic proximity Read ↗

CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course.Semantic proximity Read ↗

IL‐10 promoter haplotype influence on interferon treatment response in multiple sclerosisSemantic proximity Read ↗

Cytokines genes polymorphisms and risk of multiple sclerosis.Semantic proximity Read ↗

Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.